New Drug Shows Promise for Hard-to-Treat Ovarian Cancer
Researchers tested a new targeted cancer drug called mirvetuximab soravtansine (MIRV) on patients with ovarian cancer that had stopped responding to standard …
Read MoreAll content tagged with "ovarian cancer treatment"
Researchers tested a new targeted cancer drug called mirvetuximab soravtansine (MIRV) on patients with ovarian cancer that had stopped responding to standard …
Read MoreScientists are developing exciting new treatments called CAR-T and CAR-NK cell therapies that train the body's immune cells to fight ovarian cancer. This …
Read More